HORMONAL REPLACEMENT THERAPY AND LIPIDS - IS TRANSDERMAL NORETHISTERONE ACETATE BETTER THAN ORAL MEDROXYPROGESTERONE ACETATE, (VOL 1, PG 119, 1994)

被引：0
|
作者：
PANSINI, F
ALBERTAZZI, P
BONACCORSI, G
ZANOTTI, L
CAMPOBASSO, C
VIGNA, G
PISATI, R
MOLLICA, G
机构：
来源：
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 1995年 / 2卷 / 01期
关键词：
D O I：
10.1097/00042192-199502010-00009
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
[No abstract available]
引用
收藏
页码：53 / 53
页数：1
相关论文
共 30 条
  • [1] HORMONAL REPLACEMENT THERAPY AND LIPIDS - IS TRANSDERMAL NORETHISTERONE ACETATE BETTER THAN ORAL MEDROXYPROGESTERONE ACETATE
    PANSINI, F
    ALBERTAZZI, P
    BONACCORSI, G
    ZANOTTI, L
    CAMPOBASSO, C
    VIGNA, G
    PISATI, R
    MOLLICA, G
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 1994, 1 (03): : 119 - 123
  • [2] The influence of transdermal oestradiol replacement therapy and medroxyprogesterone acetate on serum lipids and lipoproteins
    Bhathena, RK
    Anklesaria, BS
    Ganatra, AM
    Pinto, R
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 45 (02) : 170 - 172
  • [3] TRANSDERMAL ESTRADIOL PLUS ORAL MEDROXYPROGESTERONE ACETATE REPLACEMENT THERAPY IN PRIMARY AMENORRHEIC ADOLESCENTS - CLINICAL, HORMONAL AND METABOLIC ASPECTS
    CREATSAS, G
    AREFETZ, N
    ADAMOPOULOS, PN
    KONSTANTELLOU, E
    ARAVANTINOS, D
    [J]. MATURITAS, 1994, 18 (02) : 105 - 114
  • [4] SERUM-LIPIDS DURING TREATMENT WITH TRANSDERMAL ESTRADIOL AND ORAL NORETHISTERONE ACETATE
    MUCK, AO
    SALBACH, B
    RABE, T
    VONHOLST, T
    RUNNEBAUM, B
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 1995, 55 (07) : 393 - 399
  • [5] Effects of progestogen on lipids, lipoproteins and apolipoproteins during transdermal estrogen replacement therapy with and without medroxyprogesterone acetate
    CasteloBranco, C
    Casals, E
    Sanllehy, C
    Duran, M
    Fortuny, A
    Vanrell, JA
    [J]. JOURNAL OF REPRODUCTIVE MEDICINE, 1996, 41 (11) : 833 - 838
  • [6] TRANSDERMAL ESTRADIOL AND MEDROXYPROGESTERONE ACETATE IN HORMONE REPLACEMENT THERAPY ARE BOTH ANTIOXIDANTS
    TRANQUILLI, AL
    MAZZANTI, L
    CUGINI, AM
    CESTER, N
    GARZETTI, GG
    ROMANINI, C
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 1995, 9 (02) : 137 - 141
  • [7] COMPARATIVE-STUDY OF THE EFFECTS OF NOMEGESTROL ACETATE AND NORETHISTERONE ACETATE ON LIPIDS DURING REPLACEMENT THERAPY OF MENOPAUSE
    DORANGEON, P
    THOMAS, JL
    LUMBROSO, M
    PARIS, J
    DORANGEON, PH
    [J]. ANNALES D ENDOCRINOLOGIE, 1987, 48 (03) : 264 - 264
  • [8] Antithrombin III, protein C and protein S activities in serum of postmenopausal women treated with hormonal replacement therapy (transdermal estradiol and medroxyprogesterone acetate orally)
    Ciepluch, R
    Czestochowska, E
    [J]. THROMBOSIS AND HAEMOSTASIS, 1997, : P3016 - P3016
  • [9] Effects on haemostasis of hormone replacement therapy with transdermal estradiol and oral sequential medroxyprogesterone acetate: A 1-year, double-blind, placebo-controlled study
    Crosignani, PG
    Cortellaro, M
    Boschetti, C
    [J]. THROMBOSIS AND HAEMOSTASIS, 1996, 75 (03) : 476 - 480
  • [10] A randomised comparison of the effects of oral versus transdermal 17β-oestradiol, each combined with sequential oral acetate, an serum lipoprotein levels norethisterone (vol 106, pg 948, 1999)
    Spencer, C
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1999, 106 (10): : 1108 - 1108
123